🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Barclays PLC (LON:BARC)
United Kingdom flag United Kingdom · Delayed Price · Currency is GBP · Price in GBX
418.00
+1.10 (0.26%)
Nov 18, 2026, 10:56 AM GMT
← View all transcripts

J.P. Morgan UK Leaders Conference

Nov 18, 2026

Summary

The 2028 plan targets RoTE above 14%, lending growth above 5% and distributions of at least GBP 15bn. Priorities include sustained NII and cost momentum, scaling targeted investment-bank and US consumer businesses, and using technology and AI to improve efficiency.

Welcome, and thank you for standing by. I would like to inform all participants that this conference call, as well as any Q&A, may be recorded and made available to clients of J.P. Morgan. Where a company is presenting, any recording may also be posted on their website. Views and opinions expressed by any external speakers on this call are those of the speakers and not of J.P. Morgan. Parts of this conference call may also be reproduced in J.P. Morgan research. Participants are prohibited from posting, sharing, or distributing any part of this call or its content on social media platforms or any public forums without prior written consent from J.P. Morgan. If you have any objections, you may disconnect at this time. This call is intended for J.P. Morgan clients only. Press participants are not permitted on this call and should disconnect now. Equally, this call is not open to J.P. Morgan corporate clients, including their management teams and investor relations contacts, and they should also disconnect now unless otherwise agreed with the host. Unless otherwise permitted by internal J.P. Morgan policy, members of J.P. Morgan Investment and Corporate Banking are not permitted on this call and should disconnect now. I would now like to turn the call over to the J.P. Morgan host. Good morning. Great to have you here, Anna. Thank you. First of all, a lot of things are happening in the U.K., and we want to dive a little bit into that, but in particular, clearly, what is happening in Barclays. We are starting with the group maybe. Yeah, sure. Start with the original plan, the strategic plan. You are coming to the end of it. Yeah. The new plan is in for about a year. Can you give us an update on how you see 2026, how it develops relative to the plan, and also 2027? What are your expectations? Yeah, sure. Thanks for having me. We are halfway through the final quarter of our 12-quarter plan. Obviously, we had confidence when we set out at the beginning, but it is great to be in the position that we are in, which is that we have confidence around meeting all of the targets that we set out. Just to remind you, that is greater than 12% RoTE. We said that we would do at least GBP 10 billion of distributions. At the end of the third quarter, including the planned dividend, that is at GBP 10.7 billion even before we do a full-year buyback. Of course, we said we would invest more in the U.K., and we are at GBP 28 billion out of the GBP 30 billion by the end of the third quarter, and running at about GBP 2 billion a quarter. Very confident, very pleased in what we have done so far. That obviously gives us confidence for the next step, which is the next milestone, which is 2028, where we have said that we will grow our lending, continue to do that at greater than 5%, at least GBP 15 billion of distributions, and a RoTE of greater than 14%. Really, what we are focused on is actually internally beyond 2028. So, I have confidence for 2028. We are really focused beyond there, and particularly growing fee businesses, particularly improving the technology that allows us to deploy AI at scale. That is what we are thinking about. In terms of shorter term, 2027, expect more of the same. So, income momentum. A couple of things to note there. We are happy with our U.K. and group NII consensus, and that is really coming from the pace of lending growth, but also the structural hedge, not just in the U.K., but all the way across the group. We will, of course, plan for a normalized markets environment, but we still have income momentum despite that. Secondly, continued cost control, so expect positive jaws. We have set out to do that in every single year of the plan. Finally, just that stronger capital generation. We said circa 200 basis points this year. We are headed for greater than 230 in 2028. Expect something in between the two. That really gives us the opportunity both to distribute and to invest in the business. What is really important for us is that continued momentum in earnings per share, which has been running double digit for several years now, and it is really compounding nicely. Again, we expect that to continue. You mentioned you are clearly focused on the new plan and the delivery, but you also mentioned that you are looking even beyond that. Do you think you will discuss this potentially even further with the market at one point, how we should think beyond 2028? Yes. If you look at what we have done so far, in 2024, we did 2024 to 2026, and then in 2026, we did 2026 to 2028. Do not expect us to talk about beyond 2028 in February, but maybe in a year beyond that. Perfect. You mentioned you are well on track on your targets. Maybe we come back to that and we dive a little bit more into the businesses. Yeah, sure. Then we come back to the group. Maybe start with investment banking, equity sales, and trading. I mean, you had a superb quarter, third quarter, 47% up year-on-year in equities, and you have invested in this business. We wanted to understand what your position is in terms of, and how you want to position this business against your peers, as we see you are not in the top five in equities, and the U.S. players are gaining market share if you take a long-term trajectory over time. So, where are you positioned, and how do you see the future of that business? Yeah. I mean, if you look at our performance at that 47%, I don't think that is a performance that people a couple of years ago would have expected from Barclays. It is really that investment coming to fruition. You might remember that when we started out on our plan at the beginning of 2024, we actually had in mind three focus businesses and financing. They were the areas that we wanted to lean into to continue to grow and stabilize the IB. One of those focus businesses was in equities, and that was equity derivatives. Obviously, in financing, you have prime. 90% of the growth that we have seen in our equities business comes from derivatives and prime, which are the things that we have invested in. We really feel like we have done this, and this has happened. That is very pleasing, and it means that we can be more successful in a range of economic environments. It really speaks to what we are trying to do to improve the stability of the investment banking earnings. That is very important to us. In terms of how we compete or where our edge is, it is really around focus. From our perspective, you are exactly right. We are typically number six as an investment bank, but where we compete, we seek to be above that level. We are very focused geographically. Ours is largely a U.K., U.S., European business, less so Asia. We are very focused in terms of our clients, and we have spoken a lot about, are we top five with our top 100 clients? That number was down at 30. We are currently at 66. We want it to be 70 or more. That is really important. Then again, just around products and thinking about the product adjacencies. Our thought process at the beginning of this was we are very strong in fixed income financing, therefore we should be strong in prime. Taking those two together, running them as a single business, and we do think that is an edge that we have here because we run it as a single business, single technology, single view of risk. That means that we can be very, very responsive to our clients, who tend to be the larger global multi-strat funds. We can be very responsive to them across the entirety of the product set that they want. That is really important to us. Once you are good in prime, you then go derivatives. Sort of edging- out, if that makes sense, as opposed to opening the waterfront everywhere. That is really how we like to compete. Within prime, you have done a great job of growing the prime business. Clearly, there is a lot of players focusing on that business. Yeah. What do you see in terms of margin or return on assets? Do you see margin pressure developing in this business, or is it still extremely profitable? It is still profitable, and obviously, this is a leverage-heavy business, not an RWA-heavy business, so the returns are good. Obviously, for us, we raise AT1 in order to compete in this business. Barclays is quite unique in that we both have a residential mortgage business and a prime business. We are quite unique in the globe in having both of those. So, we are a disproportionate issuer of AT1. That costs us money, so I am very focused on that, but it means I have a very clear marginal cost. So, that is what I keenly look at. We talk to you about RWAs and return on RWAs. On the inside of the bank, I am equally focused on that return on leverage balance sheet. So, happy with that. It is a very competitive business, always is. Yeah. So, really, the way that you compete is through client focus, again. So, 98 of our top 100 clients do financing with us. That is really important. And we see that cross-fertilization between financing and trading as being very, very important. And also, that way in which we manage the business across both prime and fixed income financing, we think is really important about client selection and also the way we service them. Yeah. We estimate that prime clients buy about 2.4, 2.5 products from investment banks. That is our estimate, clearly. We would agree. Yes. It is a big multiplier effect, as you say. Yeah. Moving to fixed income. Yeah. A bit softer, minus 19% year-on-year in the third quarter. Can you talk about how you are allocating investments between equity, fixed income, how that works, and how you position yourself in fixed income? Yeah, sure. I mean, I said we had three focused businesses. One of them was equities. The other two were in FICC. Our securitized products business, our European rates business. If I take all of those three together, they have grown their market share significantly. I think it is important within FICC to sort of dive to the level below and say, "How do we feel we did?" If you look at our securitized products business, it is smaller for us, but that is growing really nicely. So we were pleased with that. I think across the entirety of the market, we saw some subdued activity in rates. That is a big business for us, so probably impacted us a little bit more. I would say credit intermediation in general, particularly in the second half of the quarter, was a bit more difficult. There were some big macro moves that made that even worse, I think. As I look at Q4 feels like another good quarter for equities, a more difficult quarter for FICC. Again, just as I look at the market wide, it is still early, but that is what we would call out. It feels like we have still got things to do within FICC in terms of particularly around European rates. But those businesses have the technology, they have the capital associated with them. It is not that we are not investing in them. Back to my point, there are two out of the three of our focus businesses were there. So, important that we continue to focus. But I would say that just as you look at the balance of the business this year overall for the market, we have clearly had an elevated markets wallet this year. I just remind you all that when we plan, we plan for a normalized markets wallet. Normalized for us, you can see that our assumption has been about GBP 135 billion. The market is significantly higher than that right now. We will be building that conservatism into the way we plan for 2027. Despite that, we still think that we will hit our targets. That is very helpful. Yes. If you look at the, if we move maybe out of the Investment Bank and we look at net interest margins. Yeah. Some U.K. peers have highlighted flatter NIM trajectories for 2027. You do not give a NIM forecast. You talked about NII briefly at the beginning of our discussion. How should we think about the drivers on NII for 2027, competition on the deposit side, and also the wholesale funding cost? Yeah, sure. We are explicitly not guiding to NIM. The reason for that is clearly what we are trying to do is grow our asset base. If I grow my mortgages very quickly, then NIM might go down. That is not a bad thing because my NII will be higher. We are very focused on NII. We have said that we expect momentum into next year, not just for the U.K., but elsewhere. Your deposit comment, let me start with the U.K. and then I will go more broadly. I mean, there is clearly competition in the market, and that we think is driven by funding. We said that on our call, and I think that is fairly consistent across the U.K. peers. We clearly are in a slightly different position. Our LCR is 158% in the U.K. ring-fenced bank, which is where BUK sits within that. We have more optionality here to step back and take more of a relationship lens. Perhaps less of a pressure for us, but we do observe it, and we observe it both through term funding, but also through the amount of covered bonds that have been issued across the last year or so is clearly significant in the U.K. I would say as we look at it now, term savings costs appear to have stabilized a little. They are moving a bit more with swaps, but I would just call out, we are not in ISA season. Q1 could be different, but Q4 is a bit more stable. But I think the funding point remains, but given our lending growth, given the success that we have had with growing our Premier proposition, which is where really you get that stability of funding from, and also the structural hedge, we are confident in that BUK NII trajectory. The same story extends across the rest of the bank, because remember, the structural hedge is not just BUK. It is corporate, it is the ICB, it is PBWM, and increasingly into the IB more generally and into USCB because it is also the equity structural hedge, which gets allocated according to RWAs. And of course, we have got lending growth also meaningfully in corporate. We have got good organic growth in U.S. cards. NII is a multi-jurisdictional, multi-business growth for us. And, when you said you see at the moment a bit more, is it correct to say maybe stability? It's moving with swaps. Yeah, moving with swaps. Okay, that's good to know. You don't see that conversion aggressively into term at this point? It's still there, but it's moving with swaps. Yeah. My slight caution is obviously the majority of the maturities in the market will be in Q1 and Q2 associated with the ISAs. ISAs. That is helpful. You are clearly sticking with your overall guidance otherwise. Yeah No change there. Moving from U.K. to the U.S. Yeah. US Consumer Bank, the RoTE is expected to move to mid-teens by 2028. You have the RWA density from the IRB models coming through. Yeah. You are moving from 109 density to 152, or 150. Can you talk a little bit about that? You had some headwinds as well in the third quarter. Yeah 20 million on the non-NII there, which seems like it is more, could be an issue going forward with higher rates. Can you talk a little bit about your expectation for this business? Is there room for repricing, competition, how do you see this business developing? Yeah, sure. It seems a bit tougher. Yeah, I mean, just to reassure everybody, we have always planned for this RWA coming. Yeah. Clearly, the timing of that has moved out. We cannot control the timing of regulatory approvals. As we have been repricing transactions or re-pitching for transactions or pitching for new partnerships, that is the capital level that we have used in our assumptions, and we are still winning those. So we have confidence that we can still continue to win partners. Actually, over 85% of our partner balances are secure till at least 2030. So we are in a good position to make the kind of transition in that IRB situation. The cards business itself is doing what we wanted it to do. Organically, it is growing at 6%. The NIM was 13.7%. This is our most digital business, so the CIR is coming down, which is great. We will continue to push all of those levers to counteract the RWA inflation. I mean, it is a headwind. It is a differential between us and our U.S. peers. That should not stop us from making a reasonable return in this business. On Best Egg, we are originating what we said we would. The issue that we face is because rates have gone up in the market, APRs have not really, so you get a margin squeeze. Not unusual. That means that the securitized prices are a little lower than we would have hoped for. To put that in context, it is about GBP 20 million a quarter. So, we had thought that we would build back by Q4 with Best Egg and organic growth to where we were in Q1. What we are saying is we will be about GBP 20 million short of that. The action needs to be really to get that originate to distribute flow going through our end markets business, to integrate the business quickly to get the benefits out, and really to consider how we are pricing that business and how much we hold versus securitize. Those are all things that we are thinking about in order to mitigate that. We remain excited about this business. I know it is probably quite difficult to see that from the outside, but Samsung is really important here because it is us putting together our cards and deposits and loans in the same place, and we think that will teach us a lot. Actually, running a disruptive business outside of your home market, as you guys well know- is a good thing to do. We are learning a lot, not just about the U.S. market, but really how we can take that elsewhere. And you should be on track for mid-teens 2028, around there? Should be. Yeah. We are very focused on it. Yeah. Let's see how we go. This year, we expect to be around the 12, greater than 12% ex AA gain on sale. Clearly, there's always a question on US consumer, and you answered it partially discussing it clearly as a linkage with the securitization business and the markets. Yeah. There was a question, why is Barclays in the US consumer? Yeah. Also, they're always saying US consumer equals cards, which is not the case anymore. Yes. Can you discuss that? You mentioned disruptor in the market. Can you strategically talk a little bit about your thinking of USCB as part of the group? Why? To some extent also, should it actually scale up? Should it be bigger, i.e., should there be something added? We have more retail customers in the U.S. than we do in the U.K. There are 23 million in the U.S. This is a scale business, one that we have been in for 20 years, one that we know well, and it gives us an opportunity to grow in a fast-growing, significantly larger market than our home market. It is strategically very important to us. We do think about it as a consumer business, not a cards business. USCB is consumer bank, not cards business. Sometimes I get that wrong and I get told off. Yeah. There has been a really good opportunity here for us to grow deposits organically, completely digitally. That has taught us a lot. Now we are doing the same with unsecured. We do think that we can put this together in a way that is perhaps different from what we have operated before, and it gives us the opportunity to scale up. There are also linkages to other parts of the business. I talked about markets. But we are essentially providing consumer finance to our investment banking clients. That is how I think about it. Then the other thing is, there is some overlap between the U.K. business and USCB, particularly as we think about the deployment of AI. If you think about the AI tools we build for our U.K. business, they can be deployed into the U.S. and vice versa. There is connectivity and synergistic benefits there. Okay. Yeah, that is helpful. Now moving back to the group, one of the focus areas was slide nine in your pack in the third quarter, which talked about cost projection. I think you have to look at cost also in the context of revenues, clearly. Yeah. Your target is 5%+ growth in revenues until 2028, CAGR. I think consensus is about 5.7%, at least the last consensus we saw. The market is there at roughly, I think, GBP 34.4 billion of revenues. On the cost side, this year it is GBP 18.5. You guided to GBP 18.4 in 2027, and the market is wondering what will 2028 be, considering your cost income guidance, low 50s, and the market is at 55, 54. Yeah. The market is wondering, wait a minute, could they reduce cost? Is there actually room to do that in 2028? Which is clearly not priced. Could the revenues be significantly better and we are missing something? Can you unpack that a bit? Yeah, sure. I think the most notable thing people should have taken from slide nine, as well as the absolute number for 2027, was us indicating the way that we are managing costs that is different. It is a departure from where we have been historically. Because the temptation is, or the easy thing is, if you want to optimize the returns of a bank, any bank, any business, is you pull back on investment. It is clear that that is what has been done in the organization in the past. That is why in 2024, we stood up and went, "We have got to fix this and this and this and this." We are distinguishing that pattern of behavior with where we are now. Why? Because we can. Because there is a difference here between the level of capital that we are generating that allows us to distribute meaningfully and invest in the business, and also because of where we are in our technology development, we have line of sight to drive the run costs of the bank at least neutrally or down. That is what we were saying with slide nine. So if all you have taken from it is the- Yeah is the 18.4, you kind of missed quite a big signal about our intention of driving down the cost to serve of the firm. That's where we're really focused, and that's why technology's important. I'm not going to talk specifically about 2028 at this point. Yeah other than to just remind you CIR is our North Star. We expect to drive positive jaws in every year. Just think about those two things, if you like, the operating leverage, driving that hard, creating room for investment. That's how we think about it. You're thinking clearly, just to be clear, underlying cost. Yes doesn't always have to go up. Correct. It could also be having a different trajectory. Yeah. That would be particularly true of the U.K. Yeah. Your confidence on the BUK that you can reduce cost, because based on your guidance, the cost should continuously decline. You are well on track on that. Yeah. I mean, if you look at what we have executed so far, 2027 is meaningful for two reasons. If you look at slide 10- Yeah You'll see the level of structural cost actions that we've taken in BUK in the current year is meaningfully higher than the normal run rate. Yeah. That tells you that there is a reduction in FTE coming that's going to flow through that business. That's as a result of much of the investment that we have been doing, and then it starts to come to fruition. The second thing is, in 2027, we expect around GBP 100 million of Tesco benefits to flow out. That's consistent with what we said in February. So in BUK, you're going to start to see costs come down in absolute terms. That's the first part of the bank where you're going to see that happening. Mm. On cost and revenues to some extent as well, you mentioned AI and technology. Yeah Should help you on the cost side. Yeah and the revenue side as well. Can you talk about You clearly have some ideas, just big buckets. What are the opportunities that you see, especially on the cost side, if I may, if you could? Yeah, sure. I mean, I think with AI, one of the things that we set out in February was this foundational work that we are doing. The first two of those are cloud and data. Multi-cloud, we are now more than 90% done. We expect to be 100% done on data on a modern enterprise-wide data platform by the end of 2028. So that puts us in a tremendous position to deploy AI at scale, particularly for a mature bank. We are really excited about that, and we think that that foundational work is really, really important about the cost-effectiveness of the AI that you then deploy. So that's the first thing. We see significant opportunities within technology, particularly around cost and speed of deployment, per my USCB description. But we've got around 11,000 of our developers now using Claude. We've got about 25,000 using GitLab Duo. And we talked about our 5,000 FTE reduction, about 60% or more of that being from kind of support functions and technology. Essentially what we're doing is we are carefully deploying the right tools into the organization and then reaping the benefits of those as we go. That's what we're trying to do. And in so doing, we have the capability to monitor in a real-time basis the cost of tokens and manage those. So we're doing that very carefully. There are revenue opportunities. I think they're harder to say, "We did X, and therefore we get Y." But we're on the verge of doing some quite interesting things. We think that more than And the early adopter here will be USCB, again, because it's our most digital business. So, we think more than 50% of their customer journeys by 2028 will be personalized. That's deployment of AI. We are also in what I would describe as friends and family testing of our first customer-facing agentic solution there that will do account servicing, help the customer with their balance management, et cetera. That's really, really exciting. I think the other thing that we are very focused on is just equipping all our colleagues to use this sensibly, responsibly. So that's in part training and retraining, because there is no doubt the shape of the firm will change. We have some reskilling to do, whether those people stay with us or go on somewhere else, and we think that is really important. We will be spending about GBP 150 million over the next few years in that reskilling. AI is becoming a bigger part of what we do, but do not think of it as anything separate. It is part of the organizational strategy, it is part of the HR strategy, it is part of the cost strategy, it is part of the revenue strategy. It is not something different sitting over here. Maybe just briefly switching from cost back to revenue, just very briefly, you mentioned also clearly your normalization of market assumptions. Yeah. You have the CAGR assumptions. The normalization of market, would that actually assume that in your budgeting, you are assuming markets to be down? Well, it depends on our market share assumptions. Yeah. I am not going to give you a specific market share bar. Yeah. But you can see that our, I think it is the last slide in our deck. Yeah. We normally assume about GBP 135 billion. That is meaningfully lower this year. Lower. Expect us to continue to grow and to progress Yeah in terms of our individual businesses, but within a smaller context. Yeah. So that gives you confidence on your cost income overall, yeah. Yeah. Moving to capital, you mentioned that you will give an update in February where you expect to operate within the 13%-14% CT1 target range. You have the Pillar 2A reduction. Yeah. Can you talk a little bit about the framework on capital, organic growth, M&A, as well as payout? Also, how should we think about, in that context, a buyback? I mean, you have the guidance in terms of buybacks of over GBP 15 billion and consensus around, last number I have is 17.7, 17.8, I think. How should we frame everything? Yeah. Our capital priorities are no different to what they were. Number one, regulatory, number two, distribution, number three, investment in the business. That is how we think about it. That is from the start, we still think about it that way. What we have had more recently is clarity on Pillar 2. That is important because we said we expected roughly 30 to 55 basis points on Pillar 1. On Pillar 2, we are now saying we have line of sight to that 59 basis points. That will reduce the MDA to 11.6%. As we set where we are going to operate, that distance to the MDA is really important to us. It is important to us not only as our long-term stability of the firm, but also in terms of our issuance of AT1, which I said was really strategically important. Expect us to be very thoughtful about that when we come and talk to you about the range that we operate within. Until we have done Basel, we have said that we will operate at the top end of our range, so that is why we are saying we will come back in February. I mean, I am not going to comment on consensus on distribution other than to say the RoTE and the distribution targets are greater than for a reason. We were very open in February, and we said that there is a capital generation within the plan that is greater than the distribution target. We want to invest in the business, and we will hold ourselves to a high bar as we do that. But, if we do not find opportunities to do that, then of course, we would distribute that to the market. Everything is going in the right direction. We have a RoTE of 15.2 by 2028. Your target is 14+. Your valuation is not reflecting that. You trade at six times earnings, 0.8 times tangible, 2028 for RoTE of 15. One of the cheaper banks in Europe. What is it that, from your perspective, now that you have gone through the group divisions, what the market is missing? In that context, how can you or what can you do to improve the valuation on a relative or absolute basis? Yeah. I think it is a perennial question. We feel like we have more to prove, and we are eager to get on and do that. While we are nearing the end of our first plan, and it feels like a long time, it is only three years. We feel like we are building up a discipline around sustainable improvement in returns, and we do feel that that sustainability and that consistent improvement is really, really important. As I look at consensus, I am really glad that consensus is now in alignment with our targets. I think where we have more to prove is beyond 2028. What does that all-weather RoTE really look like? That is beholden on us in terms of the way we continue to grow RoTE and show its stability and stability in the earnings of the firm for investors to see and realize that. More to do there. The disciplined capital allocation, I think, also remains important, our ability to grow in a very disciplined way. Same with investment. If we are investing the business like we have in prime and in equity derivatives, can the shareholder see that coming through? I think we can, but again, more to show there. I think more on distributions. As I said, we are at 10.7% versus our at least 10%. I think shareholders want to see more of a track record there, but that is what we are here for. It would be really easy for us to optimize the returns of the firm over a short period of time. That is not what we are doing. We are trying to systemically, indelibly change the way that Barclays makes money for 2028 and beyond. Do you think we could even move at one point to a more sustainable or over-the-cycle RoTE guidance rather than forward-looking for a specific period or year? To answer that would be a bit of a spoiler. Yeah. But the phrase all-weather RoTE leans towards that, Kian. Yeah. That's essentially what we mean. Yeah. If you've gone from 10 to 12 to 14, then really, where do you think your glide path is Yeah above that? Where's the floor? Where's the range? And clearly, for us, given the nature of that business, there will be a range. But I think for shareholders really to understand that we think we can meaningfully improve the returns of the firm structurally, I think is important. That is helpful. We have a little bit of time for a quick question. Mics are on the table. Please go ahead. Hi, Anna. Thanks very much. Just to pick up on the theme of the sustainability, when we last met, I was struck by the improvement in quality of earnings that you have alluded to. Is it worth just digesting what this business, how it makes money now compared to how it made money when the RoTE was either negative all over the show in the four or five years before you guys took over? Yeah, sure. Well, clearly we are in a different position because we have a U.K. business which is growing. I was the U.K. ring fence CFO. We had never had a strategic decision to grow either corporate or the Barclays UK business, and clearly that is different now. We are able to do that, again, because of the returns of that business, but also the greater capital generation of the business and the stability of it. So, that is meaningfully different. I think the other thing is also the Investment Bank, and there is a slide in the back of our presentation, which is slide 43. I apologize in advance. It is the busiest slide we have ever produced, but pictorially, it will help you. The Investment Bank, we tend to think of it as more volatile earnings. It is not, because there are many businesses within it. If you look at that chart, what you will see is that the International Corporate Bank and the financing business are growing in absolute terms, and they now cover 70% of the cost base of the Investment Bank. That is really important to us because it means in periods of down volatility, you have got much more operating leverage in that business. So, that is important. The other thing is really around the growth in equities, which in and of itself balances the business. Because when you are a FICC-driven or a fixed income-driven house, either in banking or in markets, that means that you will outperform in some quarters and underperform in others. The result that we achieved in equities is very strategically significant in the third quarter. So, I think that stability of earnings is within the Investment Bank and outwith it. I guess we see it also in the VaR numbers Yes, exactly. that you disclose, which are Pretty stable. loss ratios are very low. Yeah and days of losses are Yeah almost nonexistent. Absolutely. Thank you very much, Anna. Thank you so much for joining us. Thank you.